Performance of the 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort

被引:0
|
作者
Cime-Ake, Erik [1 ]
Hernandez-Molina, Gabriela [2 ]
Llorente-Chavez, Amaya [3 ]
Martin Nares, Eduardo [2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Dept, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematol Dept, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0118
引用
收藏
页码:231 / 233
页数:3
相关论文
共 50 条
  • [1] 2023 ACR/EULAR antiphospholipid syndrome classification criteria
    Barbhaiya, Medha
    Zuily, Stephane
    Naden, Ray
    Hendry, Alison
    Manneville, Florian
    Amigo, Mary-Carmen
    Amoura, Zahir
    Andrade, Danieli
    Andreoli, Laura
    Artim-Esen, Bahar
    Atsumi, Tatsuya
    Avcin, Tadej
    Belmont, Michael H.
    Bertolaccini, Maria Laura
    Branch, D. Ware
    Carvalheiras, Graziela
    Casini, Alessandro
    Cervera, Ricard
    Cohen, Hannah
    Costedoat-Chalumeau, Nathalie
    Crowther, Mark
    de Jesus, Guilherme
    Delluc, Aurelien
    Desai, Sheetal
    De Sancho, Maria
    Devreese, Katrien M.
    Diz-Kucukkaya, Reyhan
    Duarte-Garcia, Ali
    Frances, Camille
    Garcia, David
    Gris, Jean-Christophe
    Jordan, Natasha
    Leaf, Rebecca K.
    Kello, Nina
    Knight, Jason S.
    Laskin, Carl
    Lee, Alfred I.
    Legault, Kimberly
    Levine, Steve R.
    Levy, Roger A.
    Limper, Maarten
    Lockshin, Michael D.
    Mayer-Pickel, Karoline
    Musial, Jack
    Meroni, Pier Luigi
    Orsolini, Giovanni
    Ortel, Thomas L.
    Pengo, Vittorio
    Petri, Michelle
    Pons-Estel, Guillermo
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1258 - 1270
  • [2] 2023 ACR/EULAR antiphospholipid syndrome classification criteria
    Barbhaiya, Medha
    Zuily, Stephane
    Hendry, Alison M.
    Manneville, Florian
    Guillemin, Francis
    Costenbader, Karen H.
    Erkan, Doruk
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03)
  • [3] 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
    Barbhaiya, Medha
    Zuily, Stephane
    Naden, Ray
    Hendry, Alison
    Manneville, Florian
    Amigo, Mary-Carmen
    Amoura, Zahir
    Andrade, Danieli
    Andreoli, Laura
    Artim-Esen, Bahar
    Atsumi, Tatsuya
    Avcin, Tadej
    Belmont, Michael H.
    Bertolaccini, Maria Laura
    Branch, D. Ware
    Carvalheiras, Graziela
    Casini, Alessandro
    Cervera, Ricard
    Cohen, Hannah
    Costedoat-Chalumeau, Nathalie
    Crowther, Mark
    de Jesus, Guilherme
    Delluc, Aurelien
    Desai, Sheetal
    De Sancho, Maria
    Devreese, Katrien M.
    Diz-Kucukkaya, Reyhan
    Duarte-Garcia, Ali
    Frances, Camille
    Garcia, David
    Gris, Jean-Christophe
    Jordan, Natasha
    Leaf, Rebecca K.
    Kello, Nina
    Knight, Jason S.
    Laskin, Carl
    Lee, Alfred, I
    Legault, Kimberly
    Levine, Steve R.
    Levy, Roger A.
    Limper, Maarten
    Lockshin, Michael D.
    Mayer-Pickel, Karoline
    Musial, Jack
    Meroni, Pier Luigi
    Orsolini, Giovanni
    Ortel, Thomas L.
    Pengo, Vittorio
    Petri, Michelle
    Pons-Estel, Guillermo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (10) : 1687 - 1702
  • [4] Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'
    Miro-Mur, Francesc A.
    Alijotas-Reig, Jaume
    Anunciacion-Llunell, Ariadna
    Marques-Soares, Joana
    Esteve-Valverde, Enrique
    Pardos-Gea, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03) : e2 - e2
  • [5] Performance of the 2023 American College of Rheumatology/EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort
    Cime-Ake, Erik
    Hernandez-Molina, Gabriela
    Llorente-Chavez, Amaya
    Martin-Nares, Eduardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (12) : 1775 - 1779
  • [6] The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey
    Misirci, Salim
    Ekin, Ali
    Yagiz, Burcu
    Coskun, Belkis Nihan
    Dalkilic, Ediz
    Pehlivan, Yavuz
    DIAGNOSTICS, 2024, 14 (19)
  • [7] Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice
    Yang, Yaqing
    Jiang, Haiyue
    Tang, Zihan
    Pan, Haoyu
    Liu, Honglei
    Cheng, Xiaobing
    Su, Yutong
    Ye, Junna
    Hu, Qiongyi
    Meng, Jianfen
    Chi, Huihui
    Zhou, Zhuochao
    Jia, Jinchao
    Yang, Chengde
    Shi, Hui
    Teng, Jialin
    Liu, Tingting
    JOURNAL OF AUTOIMMUNITY, 2024, 146
  • [8] NEW (ACR/EULAR) ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA
    Erkan, Doruk
    LUPUS SCIENCE & MEDICINE, 2023, 10 (SUPPL_2): : A4 - A5
  • [9] Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
    Jacobs, Lucas
    Wauters, Nader
    Lablad, Yahya
    Morelle, Johann
    Taghavi, Maxime
    ANTIBODIES, 2024, 13 (01)
  • [10] Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy
    Martinez-Taboada, Victor M.
    Gomez, Ana Micieces
    del Barrio-Longarela, Sara
    Merino, Ana
    Comins-Boo, Alejandra
    Lopez-Hoyos, Marcos
    Riancho-Zarrabeitia, Leyre
    Galvez, Rafael
    Hernandez, Jose L.
    DIAGNOSTICS, 2024, 14 (19)